Publications by authors named "M A Kulebyakina"

Establishing the molecular and cellular mechanisms of fibrosis requires the development of validated and reproducible models. The complexity of in vivo models challenges the monitoring of an individual cell fate, in some cases making it impossible. However, the set of factors affecting cells in vitro culture systems differ significantly from in vivo conditions, insufficiently reproducing living systems.

View Article and Find Full Text PDF

Multipotent mesenchymal stromal cells (MSCs) integrate hormone and neuromediator signaling to coordinate tissue homeostasis, tissue renewal and regeneration. To facilitate the investigation of MSC biology, stable immortalized cell lines are created (e.g.

View Article and Find Full Text PDF
Article Synopsis
  • Multipotent mesenchymal stromal cells (MSCs) play a crucial role in tissue repair by secreting proteins that can inhibit fibrosis development, particularly by affecting fibroblast differentiation into myofibroblasts.
  • Research showed that dividing MSC secretome into subfractions—extracellular vesicles (EV) and soluble factors (SF)—enhances their antifibrotic effects in lab settings by preventing this differentiation.
  • A proteomic analysis indicated that conditioned medium (CM) from MSCs contains activators of the NF-κB pathway, which helps regulate gene expression related to fibroblast function, while EV and SF are rich in factors associated with important signaling pathways, influencing therapeutic strategies involving MSCs.
View Article and Find Full Text PDF

The development of tissue fibrosis is a complex process involving the interaction of multiple cell types, which makes the search for antifibrotic agents rather challenging. So far, myofibroblasts have been considered the key cell type that mediated the development of fibrosis and thus was the main target for therapy. However, current strategies aimed at inhibiting myofibroblast function or eliminating them fail to demonstrate sufficient effectiveness in clinical practice.

View Article and Find Full Text PDF

Cell sheet (CS) engineering using mesenchymal stromal cells (MSC) draws significant interest for regenerative medicine and this approach translates to clinical use for numerous indications. However, little is known of factors that define the timing of CS assembly from primary cultures. This aspect is important for planning CS delivery in autologous and allogeneic modes of use.

View Article and Find Full Text PDF